跳至主要内容
临床试验/NCT02776514
NCT02776514已完成2 期

Intraarticular Injections of Steroids, Hyaluronic Acid or Platelet Rich Plasma Versus Placebo for the Knee Osteoarthritis

Balgrist University Hospital1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2016年2月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
120
试验地点
1
主要终点
Pain assessment

研究概览

简要总结

This study investigates clinical outcome and imaging outcome parameters after intraarticular injection of steroids, platelet-rich-plasma (prp), hyaluronic acid or placebo in patients with early osteoarthritis of the knee joint.

详细描述

Osteoarthritis of the knee joint is a very common disease in middle aged and elderly patients. This study evaluates the efficiency of different commonly used substances for intraarticular, non-operative treatment in early stages of this disease.

120 patients receive an fluoroscopic guided injection in the knee joint: 30 patients get injection with steroids 30 patients get injection with prp 30 patients get injection with hyaluronic acid 30 patients get injection with placebo (iopamiro contrast media)

Primary outcome: - clinical outcome (pain using numeric rating scale)

  • Magnetic Resonance imaging (cartilage defects etc.)

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究组 & 干预措施

Triamcort (1 ml, 40 mg/ml)

Active Comparator

30 patients receive intraarticular injection with steroids (and contrast media Iopamiro 200)

干预措施: Triamcort (Drug)

Platelet-rich-plasma (PRP 3 ml)

Active Comparator

30 patients receive intraarticular injection with platelet-rich-plasma (PRP) (and contrast media Iopamiro 200)

干预措施: Platelet-rich-plasma (Drug)

Suplasyn1-shot (60 mg/ ml)

Active Comparator

30 patients receive intraarticular injection with hyaluronic acid (and contrast media Iopamiro 200)

干预措施: Suplasyn1 (Drug)

Placebo (Iopamiro 200)

Placebo Comparator

30 patients receive intraarticular injection with contrast media only

干预措施: Placebo (Drug)

结局指标

主要结局

Pain assessment

时间窗: up to 24 months after injection

numeric rating scale (NRS) and WOMAC

Magnetic Resonance imaging

时间窗: up to 12 months after injection

T2-values in cartilage (mean Signal +/- Standard Deviation) in subregions

次要结局

  • WOMAC score (stiffness, difficulty)(up to 24 months after injection)
  • Knee mobility and thigh circumference(3 month after injection)
  • Tegner Activity Scale(up to 24 months after injection)

研究者

发起方
Balgrist University Hospital
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验